Shikiar Asset Management Inc Allogene Therapeutics, Inc. Transaction History

Shikiar Asset Management Inc

$335 Million
Q1 2025

A detailed history of Shikiar Asset Management Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 15,750 shares of ALLO stock, worth $22,837. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,750

Previous 15,750 -0.0%

Holding current value

$22,837

Previous $34,000 32.35%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$4.53 - $6.74 $33,975 - $50,550	-7,500 Reduced 32.26%	15,750 $78,000
Q4 2021 Jan 21, 2022	SELL	$13.13 - $24.52 $20,154 - $37,638	-1,535 Reduced 6.19%	23,250 $347,000
Q3 2021 Oct 29, 2021	SELL	$21.01 - $27.64 $65,131 - $85,684	-3,100 Reduced 11.12%	24,785 $637,000
Q2 2021 Jul 16, 2021	BUY	$23.49 - $35.8 $72,819 - $110,979	3,100 Added 12.51%	27,885 $727,000
Q1 2021 May 05, 2021	SELL	$25.79 - $39.02 $270,795 - $409,710	-10,500 Reduced 29.76%	24,785 $875,000
Q4 2020 Feb 03, 2021	BUY	$25.24 - $43.45 $127,714 - $219,857	5,060 Added 16.74%	35,285 $891,000
Q3 2020 Oct 28, 2020	SELL	$32.38 - $44.96 $3,238 - $4,496	-100 Reduced 0.33%	30,225 $1.14 Million
Q2 2020 Aug 20, 2020	BUY	$18.39 - $54.04 $36,780 - $108,080	2,000 Added 7.06%	30,325 $1.3 Million
Q1 2020 May 01, 2020	SELL	$18.22 - $28.25 $133,370 - $206,790	-7,320 Reduced 20.54%	28,325 $551,000
Q4 2019 Jan 28, 2020	BUY	$24.82 - $31.4 $16,133 - $20,410	650 Added 1.86%	35,645 $926,000
Q3 2019 Oct 29, 2019	SELL	$26.11 - $32.99 $219,324 - $277,116	-8,400 Reduced 19.36%	34,995 $954,000
Q2 2019 Jul 25, 2019	SELL	$25.56 - $31.09 $214,448 - $260,845	-8,390 Reduced 16.2%	43,395 $1.17 Million
Q1 2019 Apr 30, 2019	BUY	$24.82 - $32.54 $312,359 - $409,515	12,585 Added 32.1%	51,785 $1.5 Million
Q4 2018 Feb 01, 2019	BUY	$22.5 - $33.3 $882,000 - $1.31 Million	39,200 New	39,200 $1.06 Million

Others Institutions Holding ALLO

# of Institutions

178

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $209M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Account

Shikiar Asset Management Inc Allogene Therapeutics, Inc. Transaction History